跳至主要内容
临床试验/NCT00915291
NCT00915291已完成不适用

Sound Prescribing Study - Assessing the Impact of Pharmaceutical Marketing and Promotional Practices on Physician Prescribing

American Medical Association8 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
133
试验地点
8
主要终点
Decision to prescribe celecoxib

研究概览

简要总结

The purpose of this study is to determine whether physicians can be educated to better handle inappropriate requests from patients for direct-to-consumer advertised prescription medications.

详细描述

Since changes in FDA regulation direct-to-consumer advertising (DTCA), pharmaceutical companies have expended increasing resources to market their products to the public. This has led to increased awareness of diseases and potential treatments, but it has also created more public demand for medications that may not be appropriate for a patient's clinical presentation. This study aims to provide physicians with the knowledge and skills required to help them address inappropriate DTCA medication requests from patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • Resident physicians in internal medicine or family medicine specialties at participating study sites

排除标准

  • Completed less than 10 months of residency

结局指标

主要结局

Decision to prescribe celecoxib

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (8)

Loading locations...

相似试验